The newly FDA-approved linvoseltamab (Lynozyfic; Regeneron) may improve access to multiple myeloma treatment by offering an off-the-shelf, outpatient option that can be administered in community ...

Following the FDA approval of linvoseltamab (Lynozyfic; Regeneron) for heavily pretreated multiple myeloma, Sundar Jagannath, MBBS, highlights its potential for earlier use, increased accessibility, ...

"The FDA approval of Lynozyfic represents meaningful progress for the multiple myeloma community," said Sundar Jagannath of Mount Sinai Hospital in New York City, who was an investigator in the ...

London: Dhruv Jurel, Karun Nair and Prasidh Krishna have been included in India’s playing eleven as England’s stand-in ...

AICC chief's statement about not becoming CM in 1999 heats up state Cong, bringing his name as a “neutral face” and possible ...